| Websites | | Articles | | Centers | | Positive Thoughts |

 

Clinical Trials in the USA

 

Web State City Key Clinical Trials
Acurian Alabama Birmingham 1,2,3,4,5 5
Acurian Alabama Montgomery 6,7 2
Acurian Arizona Scottsdale 8,9, 2
Acurian   Tucsan 10, 1
Acurian   Various 11, 1
Acurian California Duarte 12, 1
Acurian   La Jolla 3, 1
Acurian   Long Beach 13, 1
Acurian   Los Angeles 3,14,15,16, 4
Acurian   Newport Beach 17, 1
Acurian   San Francisco 18,1,1,3,3,19, 6
Acurian   Various 11, 1
Acurian Conneticut Stamford 15, 1
Acurian District Of Columbia Washington 18,9,1,1,3,3, 6
Acurian Delaware Wilmington 1,3, 2
Acurian Florida Miami Beach 3, 1
Acurian   Ocala 15, 1
Acurian   Tampa 15, 1
Acurian   Various 11, 1
Acurian Georgia Atlanta 20, 1
Acurian   Savannah 21,22 2
Acurian   Various 11, 1
Acurian Iowa Bettendorf 1, 1
Acurian   Cedar Rapids 9, 1
Acurian   Des Moines 9, 1
Acurian   Iowa City 18,1,3, 3
Acurian   Sioux City 9, 1
Acurian Illinois Arlington heights 15, 1
Acurian   Chicago 23,18,1,1,1,24,25,25,3,3,3,26,27, 13
Acurian   Decataur 25, 1
Acurian   Harvey 25, 1
Acurian   La Grange 25, 1
Acurian   Maywood 25, 1
Acurian   Peoria 9,9,25,3 4
Acurian   Skokie 15, 1
Acurian   Urbana 9, 1
Acurian   Various 11, 1
Acurian Indiana Fort Wayne 25, 1
Acurian   South Bend 25,3, 2
Acurian Kansas Wichita 9, 1
Acurian Louisiana Baton Rouge 15, 1
Acurian   Metairie 15, 1
Acurian   New Orleans 9, 1
Acurian   Various 11, 1
Acurian Massachusetts Boston 1,24,3,3,10, 5
Acurian   Swansea 28, 1
Acurian   Various 11, 1
Acurian   Worcester 1,3, 2
Acurian Maryland Baltimore 1,3,29,30, 4
Acurian   Bethesda 31, 1
Acurian   Various 11,  
Acurian Maine Augusta 1,3, 2
Acurian   Various 11,  
Acurian Michigan Ann Arbor 9, 1
Acurian   St Joseph 25, 1
Acurian Minnesota Duluth 9, 1
Acurian   Minneapolis 9,1,3,3, 4
Acurian   Rochester 9,32, 2
Acurian   Saint Cloud 9, 1
Acurian   Various 11,  
Acurian Missouri Columbia 3,3, 2
Acurian   Saint Louis 1,3,3,33, 4
Acurian   Various 11,  
Acurian North Carolina Chapel Hill 1,3,34, 3
Acurian   Durham 1,1,3,3, 4
Acurian   Goldsboro 34, 1
Acurian   Greenville 34, 1
Acurian   Winston Salem 18,1,1,3,3,34,35, 7
Acurian North Dakota Bismarck 9, 1
Acurian   Fargo 9, 1
Acurian   Grand Forks 9, 1
Acurian Nebraska Omaha 9,3, 2
Acurian New Hampshire Lebanon 18,3,36 3
Acurian Nevada Las vegas 3, 1
Acurian New York Bronx 37, 1
Acurian   Buffalo 1,1,3,3, 4
Acurian   Fresh Meadows 38, 1
Acurian   Garden City 20, 1
Acurian   Glens Falls 15, 1
Acurian   Great Neck 15, 1
Acurian   Manhasset 18,1,1,3,3,37, 6
Acurian   New York 39,40,1,1,41,24,3,3,3,42,37,37,37,43,30,30, 16
Acurian   Syracuse 1,1,3,3,3, 5
Acurian   Various 11,  
Acurian Ohio Columbus 18,1,3, 3
Acurian   Toledo 9, 1
Acurian Oklahoma Tulsa 44,9, 2
Acurian Pennsylvania Danville 9, 1
Acurian   Philadelphia 45,30, 2
Acurian   Pittsburgh 24,3, 2
Acurian   Various 11,  
Acurian Rhode Island Pawtucket 24, 1
Acurian   Providence 1,24,24,24,3 5
Acurian South Carolina Charleston 3,34, 2
Acurian   Greenville 1,3,34, 3
Acurian   Spartanburg 34, 1
Acurian   Various 11,  
Acurian South Dakota Rapid City 9, 1
Acurian   Sioux Falls 9, 1
Acurian Tennesee Memphis 1,1,3,3 4
Acurian Texas Arlington 15, 1
Acurian   Austin 15, 1
Acurian   Houston 24,46,47,48,49,50,51,15, 8
Acurian   San Antonio 10, 1
Acurian   Tyler 15, 1
Acurian   Various 11,  
Acurian Virginia Richmond 1,1,3,3,15, 5
Acurian Vermont Bennington 1,3, 2
Acurian   Burlington 3, 1
Acurian   White River Junction 3, 1
Acurian Washington Seattle 30, 1

Key - Description of trials

  1. Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
  2. Phase II Study of CI-1040 in Patients With Advanced Non-Small Cell Lung, Breast, Colon, or Pancreatic Cancer
  3. Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
  4. A Study to Test the Effectiveness of Virulizin® Given in Combination with Standard Chemotherapy for Pancreatic Cancer
  5. A multicenter phase 2 study of CI-1040 in patients with advanced nonsmall-cell lung cancer, breast cancer, colon cancer, or pancreatic cancer
  6. Combination Chemotherapy Plus Radiation Therapy With or Without R115777 in Treating Patients With Locally Advanced Pancreatic Cancer
  7. Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
  8. A Safety and Tolerability Study of Oral TAK-165 Administered to Subjects with Tumors Known to Express HER2
  9. Phase II Study of Gemcitabine, Cisplatin, and Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
  10. Phase I Study of Erlotinib in Combination With Gemcitabine in Patients With Recently Diagnosed, Gemcitabine-Naive, Locally Advanced or Metastatic Pancreatic Carcinoma or Other Potentially Responsive Solid Tumor
  11. An Open Label, Randomized, Controlled, Phase III, Multi-center, Clinical Trial of PN401 with High Dose 5-Fluorouracil (5FU) versus Gemcitabine for Treatment of Patients with Advanced Pancreatic Cancer
  12. High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
  13. Phase III Randomized Study of Exatecan Mesylate and Gemcitabine Versus Gemcitabine Alone in Patients With Chemotherapy-Naive Locally Advanced or Metastatic Cancer of the Exocrine Pancreas
  14. OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
  15. A Randomized Placebo Controlled Study of OSI-774 (Tarceva) Plus Gemcitabine in Patients with Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
  16. Vaccine Therapy in Treating Patients With Advanced Cancers
  17. Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer
  18. Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
  19. Magnetic-Targeted Doxorubicin in Treating Patients with Cancer Metastatic to the Liver
  20. Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer
  21. Pancreatic Cancer (2)
  22. Pancreatic Cancer (1)
  23. Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
  24. Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
  25. Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer
  26. Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
  27. Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
  28. Study for patients with a histologic diagnosis of pancreatic cancer.
  29. LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
  30. Phase II Study of DHA-Paclitaxel in Patients With Metastatic Carcinoma of the Pancreas
  31. Vaccine Therapy with Tumor Specific Mutated RAS Peptides and IL-2 or GM-CSF for Adult Patients with Solid Tumors
  32. Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
  33. UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors
  34. Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer
  35. Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas
  36. Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
  37. Phase II Study of Sequential Paclitaxel and Bryostatin 1 in Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
  38. Pancreatic - Advanced Cancer Treatment
  39. Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  40. Phase II Study of Acupuncture and Acupressure in Patients With Moderate or Severe Pain Related to Stage III or IV Pancreatic Cancer
  41. Gemcitabine Compared With Pancreatic Enzyme Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
  42. Combination Chemotherapy Followed by Chemotherapy and Radiation therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
  43. Phase II Study of Thalidomide in Patients With Metastatic Low-Grade Neuroendocrine Tumors
  44. Immunotherapy in combination with gemcitabine in patients with locally advanced (nonresectable Stage II and III), recurrent disease following primary resection, or metastatic (Stage IV) adenocarcinoma of the pancreas.
  45. Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
  46. Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Adenocarcinoma Of The Pancreas
  47. Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
  48. Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
  49. A Phase I-II Clinical Trial of Cisplatin (Platinol) followed by Gemcitabine HCL (Gemzar) in Combination with Mild, Fever-Range Whole-Body Hyperthermia (LL-WBH) at 40.0 oC (104 oF) in Patients with Advanced Malignancies
  50. UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
  51. Phase II Study of Gemcitabine-Based Chemoradiation and TNP-470 for Patients with Locally Advanced, Nonmetastatic Adenocarcinoma of the Pancreas